These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 23810837)
21. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211 [TBL] [Abstract][Full Text] [Related]
22. Genome network medicine: innovation to overcome huge challenges in cancer therapy. Roukos DH Wiley Interdiscip Rev Syst Biol Med; 2014; 6(2):201-8. PubMed ID: 24318985 [TBL] [Abstract][Full Text] [Related]
23. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969 [TBL] [Abstract][Full Text] [Related]
25. Autophagy in cancer: good, bad, or both? Hippert MM; O'Toole PS; Thorburn A Cancer Res; 2006 Oct; 66(19):9349-51. PubMed ID: 17018585 [TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification. Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386 [TBL] [Abstract][Full Text] [Related]
27. Autophagy in disease: a double-edged sword with therapeutic potential. Martinet W; Agostinis P; Vanhoecke B; Dewaele M; De Meyer GR Clin Sci (Lond); 2009 May; 116(9):697-712. PubMed ID: 19323652 [TBL] [Abstract][Full Text] [Related]
28. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Menendez JA; Colomer R; Lupu R Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy. Nagelkerke A; Bussink J; Geurts-Moespot A; Sweep FC; Span PN Semin Cancer Biol; 2015 Apr; 31():99-105. PubMed ID: 24933034 [TBL] [Abstract][Full Text] [Related]
30. Autophagy Regulatory Network - a systems-level bioinformatics resource for studying the mechanism and regulation of autophagy. Türei D; Földvári-Nagy L; Fazekas D; Módos D; Kubisch J; Kadlecsik T; Demeter A; Lenti K; Csermely P; Vellai T; Korcsmáros T Autophagy; 2015; 11(1):155-65. PubMed ID: 25635527 [TBL] [Abstract][Full Text] [Related]
31. [Development of anti-cancer drugs mediated by apoptosis and autophagy]. Shimizu S Nihon Rinsho; 2015 Aug; 73(8):1302-7. PubMed ID: 26281682 [TBL] [Abstract][Full Text] [Related]
32. Statins, autophagy and cancer metastasis. Zhang J; Yang Z; Xie L; Xu L; Xu D; Liu X Int J Biochem Cell Biol; 2013 Mar; 45(3):745-52. PubMed ID: 23147595 [TBL] [Abstract][Full Text] [Related]
33. Free radicals in cross talk between autophagy and apoptosis. Kaminskyy VO; Zhivotovsky B Antioxid Redox Signal; 2014 Jul; 21(1):86-102. PubMed ID: 24359220 [TBL] [Abstract][Full Text] [Related]
34. Autophagy regulation and its role in cancer. Lorin S; Hamaï A; Mehrpour M; Codogno P Semin Cancer Biol; 2013 Oct; 23(5):361-79. PubMed ID: 23811268 [TBL] [Abstract][Full Text] [Related]
35. Autophagy, a double-edged sword in anti-angiogenesis therapy. Liu J; Fan L; Wang H; Sun G Med Oncol; 2016 Jan; 33(1):10. PubMed ID: 26715036 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment. Yoshida GJ J Hematol Oncol; 2017 Mar; 10(1):67. PubMed ID: 28279189 [TBL] [Abstract][Full Text] [Related]
37. Stress management by autophagy: Implications for chemoresistance. Huang Z; Zhou L; Chen Z; Nice EC; Huang C Int J Cancer; 2016 Jul; 139(1):23-32. PubMed ID: 26757106 [TBL] [Abstract][Full Text] [Related]
39. Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies. Reyjal J; Cormier K; Turcotte S Adv Exp Med Biol; 2014; 772():167-88. PubMed ID: 24272359 [TBL] [Abstract][Full Text] [Related]
40. The update on transcriptional regulation of autophagy in normal and pathologic cells: A novel therapeutic target. Zhang Z; Guo M; Zhao S; Xu W; Shao J; Zhang F; Wu L; Lu Y; Zheng S Biomed Pharmacother; 2015 Aug; 74():17-29. PubMed ID: 26349958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]